B-LBL tumor cells are virtually always positive for B-cell markers CD19, CD79a, and CD22, and may be associated with the presence of leukemia rearrangements such as those involving ETV6, MLL, or ABL1 [183]. The gene discussed is ABL1; the disease is leukemia.